Drs. Nasser Hanna and Melissa Johnson discuss developments in Immunotherapy since ASCO 2013.

Drs. Nasser Hanna and Melissa Johnson discuss developments in Immunotherapy since ASCO 2013.

Drs. Nasser Hanna and Melissa Johnson discuss developments in Immunotherapy since ASCO 2013.

Immunotherapy: What Has a Year’s Experience Taught Us Since ASCO 2013?

Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers.  The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit CancerGRACE.org for more info.

Science

Medicine

Health & Fitness

Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit CancerGRACE.org for more info.

Share Immunotherapy: What Has a Year’s Experience Taught Us Since ASCO 2013?

Sign up to save your podcasts

Immunotherapy: What Has a Year’s Experience Taught Us Since ASCO 2013?

Immunotherapy: What Has a Year’s Experience Taught Us Since ASCO 2013?